• Species Reactivity

  Human

• Specificity

  Detects human LIMD1 in direct ELISAs.

• Source

  Monoclonal Mouse IgG    ₁ Clone # 919330

• Purification

  Protein A or G purified from hybridoma culture supernatant

• Immunogen

  E. coli-derived recombinant human LIMD1    
  Met1-Val143    
  Accession # Q9UGP4

• Formulation

  Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.

• Label

  Unconjugated

Applications

• Recommended    
  Concentration

  Sample

• Western Blot

  2 µg/mL

  See below

• 
  

• Immunohistochemistry

  8-25 µg/mL

  See below

• 
  

• Immunocytochemistry

  8-25 µg/mL

  See below

• 
  

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Data Examples

Preparation and Storage

• Reconstitution

  Reconstitute at 0.5 mg/mL in sterile PBS.

• Shipping

  The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

• Stability & Storage

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles.    

• 12 months from date of receipt, -20 to -70 °C as supplied.

• 1 month, 2 to 8 °C under sterile conditions after reconstitution.

• 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: LIMD1

Human LIM Domain-containing Protein 1 (LIMD1) is a ubiquitous tumor suppressor 72 kDa protein which has three LIM zinc-binding domains. Via its LIM domains LIMD1 interacts with TRAF6, SNAI2/SLUG  and SCRT1 (via SNAG domain) proteins. It also interacts with SQSTM1 and RB1, EIF4E, AGO1, AGO2, DCP2, DDX6, LATS1, LATS2, EGLN1/PHD2, EGLN2/PHD1 and EGLN3/PHD3 proteins. LIMD1 interacts with isoform 1 and isoform 3 of VHL and with SNAI1 proteins. LIMD1 localized predominantly in the cytoplasm but shuttles between cytoplasm and nucleus where it can be often detected: strong nuclear expression is indicative for a low-tumor grade and a better patient prognosis. Down-regulation  of LIMD1 is in the nuclei of neoplastic cells, is the indication for a poor prognosis of breast cancer. The correlation exists between LIMD1 and IRF4 in cell lines derived from lymphomas. In ulcerative epithelium it was found that LIMD1 has a reduced nuclear expression. LIMD1 is encoded at chromosome 3p21.3, a region which is deleted in many solid tumors and LIMD1 is down-regulated in the majority of human lung cancer samples. LIMD1 also is a regulator of both bone osetoclast and bone osteoblast development and function. Human LIMD1 shares 77% aa sequence identity with both rat and mouse LIMD1.         

• Long Name:

  LIM Domains Containing 1

• Entrez Gene IDs:

  8994 (Human); 29806 (Mouse); 316101 (Rat)

• Alternate Names:

  LIM domain-containing protein 1; LIM domains containing 1; LIMD1